/EINPresswire.com/ -- SEATTLE, WASHINGTON -- (Marketwired) -- 10/20/15 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE: VPT) announces that James Bodtke, Vice-president, Clinical Affairs & Development for the Corporation has left the Company. Ventripoint wishes to thank Mr. Bodtke for his service and wishes him well in his future endeavors.

Additional information on Ventripoint is available on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
Ventripoint Diagnostics Ltd.
George Adams
President and CEO
(206) 910-9125
gadams@ventripoint.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.